Skip to main content

Improper Access Control

CVE-2026-21997

High
8.5/10

Summary

Vulnerability in the Oracle Life Sciences Empirica Signal product of Oracle Life Science Applications (component: Common Core). Supported versions that are affected are 9.2.1-9.2.3. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Empirica Signal. While the vulnerability is in Oracle Life Sciences Empirica Signal, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Life Sciences Empirica Signal accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data. CVSS 3.1 Base Score 8.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:H/A:N).

  • LOW
  • NETWORK
  • HIGH
  • CHANGED
  • NONE
  • LOW
  • LOW
  • NONE

CWE-284 - Improper Access Control

Listed 5th in the 'OWASP Top Ten', improper (or broken) access control attacks are a fundamental type of vulnerability. This includes a broad range of design flaws that enable users to act outside of their intended permissions. They can use these privileges to gain access to restricted files and functionality such as accessing restricted information, falsifying records, destroying data, or executing commands.

References

Advisory Timeline

  • Published